Clinical Trials Browser

Terminated × Graft vs Host Disease × 90 days × Clear all

NCT04328714 2026-02-13

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Phase 1 Terminated

Graft vs Host Disease, Myelodysplastic Syndromes